Showing results (581-590 of 604) with videos related to
Sort By:
Pageof 61
Journal of Internal Medicine|November 24, 2025
Janus kinase and calcineurin-inhibitor combination in anti-MDA5 dermatomyositis: No significant survival benefit but reassuring safety profileValentine Pagis, Quentin Astouati, Lucas Pacoureau, et al.American Journal of Hematology|April 6, 2024
Efficacy and safety of mammalian target of rapamycin inhibitors in systemic mastocytosis: A nationwide French pilot studyJosquin Moraly, Julien Rossignol, Claire Rouzaud, et al.Annals of the Rheumatic Diseases|November 5, 2016
Development of the autoinflammatory disease damage index (ADDI)Nienke M Ter Haar, Kim V Annink, Sulaiman M Al-Mayouf, et al.Nature Reviews. Rheumatology|January 7, 2021
The impact of COVID-19 on rare and complex connective tissue diseases: the experience of ERN ReCONNETRosaria Talarico, Silvia Aguilera, Tobias Alexander, et al.Arthritis Care & Research|August 29, 2023
Impact of Risk Factors on COVID-19 Outcomes in Unvaccinated People With Rheumatic Diseases: A Comparative Analysis of Pandemic Epochs Using the COVID-19 Global Rheumatology Alliance RegistryJinoos Yazdany, Anna Ware, Zachary S Wallace, et al.Clinical Journal of the American Society of Nephrology : CJASN|June 7, 2023
Clinical and Prognostic Factors in Patients with IgG4-Related Kidney DiseaseAnis Chaba, Arnaud Devresse, Vincent Audard, et al.RMD Open|October 29, 2015
EULAR Sjögren's syndrome disease activity index (ESSDAI): a user guideRaphaèle Seror, Simon J Bowman, Pilar Brito-Zeron, et al.Annals of the Rheumatic Diseases|August 6, 2018
In silico validation of the Autoinflammatory Disease Damage IndexNienke M Ter Haar, Amber Laetitia Justine van Delft, Kim Valerie Annink, et al.Journal of Scleroderma and Related Disorders|November 15, 2024
Improving organisation to improve care: ERN ReCONNET organisational reference model for systemic sclerosis patients' care pathwayRosaria Talarico, Diana Marinello, Ilaria Palla, et al.The Journal of Allergy and Clinical Immunology. in Practice|January 25, 2022
Effective Anti-SARS-CoV-2 Immune Response in Patients With Clonal Mast Cell DisordersJulien Rossignol, Amani Ouedrani, Cristina Bulai Livideanu, et al.Pageof 61